July 11, 2024 — Dr. Fadi Mansour performed the first Canadian implant of BIOTRONIK’s newest pacemaker and CRT-P generation earlier this year at the Centre Hospitalier de l'Université de Montréal. The patient received an Amvia Sky HF-T QP triple chamber pacemaker device. The first implant follows the full market release of BIOTRONIK’s newest family of pacemaker and CRT-P devices, featuring patient-centric technologies for better patient care and simplified workflows.
“The Amvia Sky HF-T QP offers a significant number of advanced features, making it the most complete CRT-P on the market including streamlined care pathways,” commented Dr. Mansour after the procedure.
The Amvia Sky system offers the following new features:
- Industry-leading choice with 20 left ventricular (LV) pacing polarities, automatically tested in less than 2.5 minutes.
- CRT AutoAdapt which automatically adjusts to changes in the patient’s condition for a more personalized response.
- Enhanced Closed Loop Stimulation (CLS) rate adaptation technology.
- Atrial arrhythmia management tools, including atrial antitachycardia pacing (ATP).
- Streamlined Care Pathways.
- Next-generation MRI access with MRI Guard 24/7.
“BIOTRONIK is dedicated to continually improving our technologies, and the Amvia Sky family is a great example of this commitment,” said Angela McGonigle, Country Director BIOTRONIK Canada. “Our latest family of pacemaker and CRT-P devices offers advanced features for optimized therapy and improved workflow simplification for Allied Health Professionals.”
For more information: www.biotronik.com
August 21, 2024 
